Palladium-catalyzed in vivo bioorthogonal activation of N, N-dialkyl-α-hydroxymethyl acrylamide for efficient payload release

Abstract

The use of drug carriers plays a crucial role in ensuring the stable circulation of therapeutic agents within biological systems and their targeted delivery to specific sites, thereby enabling precise drug treatment. In this study, we developed a novel drug release carrier based on the structure of α-hydroxymethyl acrylamide. This carrier is capable of rapidly cleaving bonds and releasing the active payload (>90%) under the catalysis of the Pd (0) complex. When conjugated with the drug, the carrier demonstrated significant antitumor efficacy in a mouse tumor model. Overall, this innovative “click to release” chemistry exhibits fast kinetics and high efficiency, offering a promising new approach for drug delivery and prodrug release.

Supplementary files

Article information

Article type
Paper
Submitted
07 May 2025
Accepted
12 Jul 2025
First published
17 Jul 2025

J. Mater. Chem. B, 2025, Accepted Manuscript

Palladium-catalyzed in vivo bioorthogonal activation of N, N-dialkyl-α-hydroxymethyl acrylamide for efficient payload release

R. Shen, B. Zhang, J. Liu, M. Yi, Y. Chen and J. Fang, J. Mater. Chem. B, 2025, Accepted Manuscript , DOI: 10.1039/D5TB01090J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements